121 related articles for article (PubMed ID: 29733221)
21. Synthesis and anti-hepatocellular carcinoma activity of novel O
Zou Y; Yan C; Liu JC; Huang ZJ; Xu JY; Zhou JP; Zhang HB; Zhang YH
Chin J Nat Med; 2017 Dec; 15(12):928-937. PubMed ID: 29329650
[TBL] [Abstract][Full Text] [Related]
22. Oleanolic Acid A-lactams Inhibit the Growth of HeLa, KB, MCF-7 and Hep-G2 Cancer Cell Lines at Micromolar Concentrations.
Bednarczyk-Cwynar B; Ruszkowski P; Bobkiewicz-Kozlowska T; Zaprutko L
Anticancer Agents Med Chem; 2016; 16(5):579-92. PubMed ID: 26343139
[TBL] [Abstract][Full Text] [Related]
23. [Synthesis and anti-tumor activity of oleanolic acid derivatives].
Meng YQ; Feng CQ; Zhang LF; Zhang M; Zhao N
Yao Xue Xue Bao; 2015 Apr; 50(4):469-74. PubMed ID: 26223130
[TBL] [Abstract][Full Text] [Related]
24. Synthesis of lantadene analogs with marked in vitro inhibition of lung adenocarcinoma and TNF-α induced nuclear factor-kappa B (NF-κB) activation.
Monika ; Sharma A; Suthar SK; Aggarwal V; Lee HB; Sharma M
Bioorg Med Chem Lett; 2014 Aug; 24(16):3814-8. PubMed ID: 25027934
[TBL] [Abstract][Full Text] [Related]
25. Conjugation of Uridine with Oleanolic Acid Derivatives as Potential Antitumor Agents.
Cheng KG; Su CH; Huang JY; Liu J; Zheng YT; Chen ZF
Chem Biol Drug Des; 2016 Sep; 88(3):329-40. PubMed ID: 26990000
[TBL] [Abstract][Full Text] [Related]
26. New Alkoxy Flavone Derivatives Targeting Caspases: Synthesis and Antitumor Activity Evaluation.
Moreira J; Ribeiro D; Silva PMA; Nazareth N; Monteiro M; Palmeira A; Saraiva L; Pinto M; Bousbaa H; Cidade H
Molecules; 2018 Dec; 24(1):. PubMed ID: 30602686
[TBL] [Abstract][Full Text] [Related]
27. Targeting cancer cells with oleanolic and ursolic acid derived hydroxamates.
Wiemann J; Heller L; Csuk R
Bioorg Med Chem Lett; 2016 Feb; 26(3):907-909. PubMed ID: 26750249
[TBL] [Abstract][Full Text] [Related]
28. A rational design strategy of the novel topoisomerase II inhibitors for the synthesis of the 4-O-(2-pyrazinecarboxylic)-4'-demethylepipodophyllotoxin with antitumor activity by diminishing the relaxation reaction of topoisomerase II-DNA decatenation.
Zhao W; Chen L; Li HM; Wang DJ; Li DS; Chen T; Yuan ZP; Tang YJ
Bioorg Med Chem; 2014 Jun; 22(11):2998-3007. PubMed ID: 24775914
[TBL] [Abstract][Full Text] [Related]
29. Synthesis, structure-activity relationship and biological evaluation of novel nitrogen mustard sophoridinic acid derivatives as potential anticancer agents.
Li DD; Dai LL; Zhang N; Tao ZW
Bioorg Med Chem Lett; 2015 Oct; 25(19):4092-6. PubMed ID: 26299348
[TBL] [Abstract][Full Text] [Related]
30. Amino acid derivatives of ligustrazine-oleanolic acid as new cytotoxic agents.
Chu F; Xu X; Li G; Gu S; Xu K; Gong Y; Xu B; Wang M; Zhang H; Zhang Y; Wang P; Lei H
Molecules; 2014 Nov; 19(11):18215-31. PubMed ID: 25387350
[TBL] [Abstract][Full Text] [Related]
31. Hybrid molecule from O2-(2,4-dinitrophenyl)diazeniumdiolate and oleanolic acid: a glutathione S-transferase π-activated nitric oxide prodrug with selective anti-human hepatocellular carcinoma activity and improved stability.
Fu J; Liu L; Huang Z; Lai Y; Ji H; Peng S; Tian J; Zhang Y
J Med Chem; 2013 Jun; 56(11):4641-55. PubMed ID: 23617697
[TBL] [Abstract][Full Text] [Related]
32. The chemical and biological potential of C ring modified triterpenoids.
Siewert B; Wiemann J; Köwitsch A; Csuk R
Eur J Med Chem; 2014 Jan; 72():84-101. PubMed ID: 24361521
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and in vitro anticancer studies of novel C-2 arylidene congeners of lantadenes.
Tailor NK; Boon HL; Sharma M
Eur J Med Chem; 2013 Jun; 64():285-91. PubMed ID: 23644211
[TBL] [Abstract][Full Text] [Related]
34. Design, synthesis and cytotoxic activity of N-Modified oleanolic saponins bearing A glucosamine.
Lin YY; Chan SH; Juang YP; Hsiao HM; Guh JH; Liang PH
Eur J Med Chem; 2018 Jan; 143():1942-1958. PubMed ID: 29133061
[TBL] [Abstract][Full Text] [Related]
35. Design, synthesis and biological evaluation of heterocyclic azoles derivatives containing pyrazine moiety as potential telomerase inhibitors.
Zhang YB; Wang XL; Liu W; Yang YS; Tang JF; Zhu HL
Bioorg Med Chem; 2012 Nov; 20(21):6356-65. PubMed ID: 23018096
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and proapoptotic activity of oleanolic acid derived amides.
Heller L; Knorrscheidt A; Flemming F; Wiemann J; Sommerwerk S; Pavel IZ; Al-Harrasi A; Csuk R
Bioorg Chem; 2016 Oct; 68():137-51. PubMed ID: 27518757
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and Evaluation of a Series of Oleanolic Acid Saponins as α-Glucosidase and α-Amylase Inhibitors.
Guo T; Wu S; Guo S; Bai L; Liu Q; Bai N
Arch Pharm (Weinheim); 2015 Sep; 348(9):615-28. PubMed ID: 26207761
[TBL] [Abstract][Full Text] [Related]
38. Enantioselective synthesis and complement inhibitory assay of A/B-ring partial analogues of oleanolic acid.
Assefa H; Nimrod A; Walker L; Sindelar R
Bioorg Med Chem Lett; 2001 Jul; 11(13):1619-23. PubMed ID: 11425522
[TBL] [Abstract][Full Text] [Related]
39. Design, Synthesis, In Vitro Anti-cancer Activity, ADMET Profile and Molecular Docking of Novel Triazolo[3,4-a]phthalazine Derivatives Targeting VEGFR-2 Enzyme.
El-Helby AA; Sakr H; Ayyad RRA; El-Adl K; Ali MM; Khedr F
Anticancer Agents Med Chem; 2018; 18(8):1184-1196. PubMed ID: 29651967
[TBL] [Abstract][Full Text] [Related]
40. Design, synthesis, molecular docking and cytotoxic evaluation of novel 2-furybenzimidazoles as VEGFR-2 inhibitors.
Abdullaziz MA; Abdel-Mohsen HT; El Kerdawy AM; Ragab FAF; Ali MM; Abu-Bakr SM; Girgis AS; El Diwani HI
Eur J Med Chem; 2017 Aug; 136():315-329. PubMed ID: 28505536
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
